Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

52.3K
Overview
52.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.6K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.6K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

72.1K
Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
72.1K
What is Meiosis?01:34

What is Meiosis?

7.0K
Meiosis is the process by which diploid cells divide to produce haploid daughter cells. In humans, each diploid cell contains 46 chromosomes, half from the mother and half from the father. Following meiosis, the resulting haploid eggs or sperm only contain 23 chromosomes; however, each of these chromosomes contains a unique combination of parental information that results from the meiotic process of crossing over.
Although meiosis shares similarities with mitosis—both rely on microtubules...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring supplemental immunization strategies to reach zero-dose children in low- and middle-income countries: a scoping review.

Therapeutic advances in vaccines and immunotherapy·2026
Same author

National genomic profiling of Plasmodium falciparum antimalarial resistance in Zambian children participating in the 2018 malaria indicator survey.

Scientific reports·2026
Same author

Individual and population level uncertainty interact to determine the performance of outbreak surveillance systems.

PLoS computational biology·2026
Same author

Timing of antiretroviral treatment initiation and seropositivity to measles virus among children living with HIV in rural Zambia.

medRxiv : the preprint server for health sciences·2026
Same author

Assessing the effectiveness of school-based vaccination checks to identify and reach un - and under-vaccinated students in Zambia.

Vaccine·2026
Same author

Species composition and blood feeding patterns of understudied Anopheles mosquitoes in southern Zambia, an area of low malaria transmission.

Malaria journal·2026
Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026
Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026
Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026
Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026
Same journal

Indonesia's health reform: from pandemic mandate to the six pillars of transformation.

Lancet (London, England)·2026
Same journal

LGBTQ+ Russians increasingly avoiding doctors.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K

Measles.

William J Moss1

  • 1Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; W Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; International Vaccine Access Center, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

Lancet (London, England)
|July 5, 2017
PubMed
Summary
This summary is machine-generated.

Measles, a contagious viral illness, causes over 100,000 deaths annually. Vaccination significantly reduces measles incidence and mortality, driving efforts toward global eradication.

More Related Videos

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

3.5K
Multielectrode Array Recordings of the Vomeronasal Epithelium
08:27

Multielectrode Array Recordings of the Vomeronasal Epithelium

Published on: March 1, 2010

12.7K

Related Experiment Videos

Last Updated: Feb 27, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

3.5K
Multielectrode Array Recordings of the Vomeronasal Epithelium
08:27

Multielectrode Array Recordings of the Vomeronasal Epithelium

Published on: March 1, 2010

12.7K

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Measles is a highly contagious viral disease transmitted via the respiratory route.
  • It causes significant global mortality, though reduced by vaccination.
  • Complications, particularly pneumonia, contribute to morbidity and mortality.

Purpose of the Study:

  • To review the epidemiology and impact of measles.
  • To highlight the importance of vaccination for measles control and eradication.
  • To discuss current challenges and future directions in measles elimination efforts.

Main Methods:

  • Literature review of measles epidemiology, clinical presentation, and management.
  • Analysis of global measles incidence and mortality trends.
  • Examination of vaccination strategies and ongoing research.

Main Results:

  • Measles vaccination has drastically reduced deaths from over 2 million to over 100,000 annually.
  • Pneumonia is a major complication leading to measles-associated morbidity and mortality.
  • Global vaccination coverage has stagnated, hindering elimination efforts.

Conclusions:

  • Measles prevention through vaccination is crucial for regional elimination and global eradication.
  • Strengthening routine immunization systems and increasing two-dose vaccine coverage are essential.
  • Innovations in diagnostics and delivery methods may accelerate progress toward measles eradication.